TickerFactsScreenerDevelopers

NeuroSense Therapeutics Ltd. (NRSNW) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2020: $659.0K2021: $10.83M2022: $5.84M2023: -$1.76M2024: $2.58M2025: -$1.56M-$1.56M
2020Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$1.56M-160.4%
2024$2.58M+246.8%
2023-$1.76M-130.1%
2022$5.84M-46.1%
2021$10.83M+1544.0%
2020$659.0K—